Cargando…
Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine tumor of the skin whose incidence is rising. Multimodal treatment is crucial in the non-metastatic, potentially curable setting. However, the optimal management of patients with non-metastatic MCC is still unclear. In addition, novel insigh...
Autores principales: | Ricco, Gianluca, Andrini, Elisa, Siepe, Giambattista, Mosconi, Cristina, Ambrosini, Valentina, Ricci, Claudio, Casadei, Riccardo, Campana, Davide, Lamberti, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508588/ https://www.ncbi.nlm.nih.gov/pubmed/34638968 http://dx.doi.org/10.3390/ijms221910629 |
Ejemplares similares
-
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population‐based analysis
por: Lamberti, Giuseppe, et al.
Publicado: (2022) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Animal Sentience: Where are We and Where are We Heading?
por: Proctor, Helen
Publicado: (2012) -
Research Integrity: Where We Are and Where We Are Heading
por: Zhaksylyk, Alikhan, et al.
Publicado: (2023) -
Articular Cartilage Repair: Where We Have Been, Where We Are Now, and Where We Are Headed
por: Grande, Daniel A., et al.
Publicado: (2013)